![]() |
市場調查報告書
商品編碼
1928903
動物飼料替代蛋白市場機會、成長要素、產業趨勢分析及預測(2026年至2035年)Animal Feed Alternative Protein Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球動物飼料替代蛋白市場預計到 2025 年將達到 49 億美元,到 2035 年將達到 97 億美元,年複合成長率為 7%。

市場成長的驅動力在於永續性需求,這些需求重塑了整個飼料供應鏈的蛋白質籌資策略。與傳統畜牧生產相關的排放和土地利用所帶來的環境壓力,已被認為是促使一體化企業、製造商和零售商重新評估蛋白質投入來源的關鍵因素。替代飼料蛋白因其依賴特定產品資源、每公頃蛋白質產量高以及能夠支持長期供應穩定性等特點,被視為低影響解決方案。討論強調,在此期間,永續性目標、監管力度和創新共同加速了飼料蛋白的多元化轉型,使其擺脫對傳統飼料蛋白的依賴,並為在全球多種動物生產系統中更廣泛地商業性化應用奠定了基礎。
| 市場覆蓋範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測年份 | 2026-2035 |
| 起始值 | 49億美元 |
| 預測金額 | 97億美元 |
| 複合年成長率 | 7% |
市場接受度的進一步解釋體現在糧食安全和成本波動。 2021年至2023年,供應中斷和地緣政治不確定性推高了飼料成本,增加了生產者管理風險的壓力。替代蛋白被視為穩定的來源,可在關鍵畜牧業領域進行試驗。昆蟲飼料、發酵植物蛋白和微生物衍生成分的表現結果與傳統進口蛋白飼料相當,同時降低了對外部供應鏈的依賴。針對消化功能、腸道功能和減少抗生素依賴性的研究進一步增強了人們對替代飼料蛋白能夠促進動物健康、改善動物福利並提升高級產品定位的信心。
預計到2025年,昆蟲蛋白市佔率將達到35.1%,並在2026年至2035年間以6.8%的複合年成長率成長。市場趨勢表明,企業正逐漸擺脫對單一蛋白質來源的依賴,轉向多元化的原料組合。大型飼料生產商正將昆蟲來源的原料與微生物、藻類、真菌、酵母來源的蛋白質以及加工大豆蛋白混合使用。這種組合方式旨在平衡成本控制、永續性、營養穩定性、胺基酸最佳化以及其他與腸道健康和飼料轉換率相關的益處。
預計到2025年,家禽市場將佔33.3%的市場佔有率,到2035年將以6.8%的複合年成長率成長。策略投資正集中於高利潤的畜牧業領域,因為高價值的飼料配方能夠抵銷更高的原料成本。生產者和飼料配方生產商之間的合作日益普及,以此來開發富含替代蛋白的均衡飼料,從而支持永續性等概念,減少對傳統海洋蛋白的依賴,並在動物營養和寵物市場引入新型飼料成分。
預計到2024年,北美動物飼料替代蛋白市場規模將達11.9億美元。該地區的成長主要由尋求供應安全和環境考慮的垂直整合生產商推動。家禽飼料、特殊飼料和寵物營養領域的強勁需求持續推動著發酵蛋白、酵母衍生蛋白和單細胞蛋白的應用。美國憑藉先進的發酵基礎設施、零售商主導的永續性舉措以及對不含抗生素、定位高階且部分替代傳統豆粕的飼料解決方案的穩定需求,成為領先的國內市場。
競爭格局包括ADM、Calysta、Angel Yeast、Inova Feed、CJ Selecta、Hamlet Protein A/S、Titan Biotech、CHS、杜邦公司、AgriProtein、DeepBranch Biotechnology、AB Maury和Crescent Biotech等公司,它們都在積極開發和商業化飼料蛋白解決方案,並在全球市場推廣應用。動物飼料替代蛋白市場的企業正透過產能擴張、技術投資和策略聯盟來鞏固自身地位。許多企業正致力於擴大發酵和昆蟲生產系統的規模,以提高成本競爭力和供應可靠性。隨著企業整合多種蛋白質形式以滿足不同的營養和監管要求,產品組合多元化變得日益重要。
The Global Animal Feed Alternative Protein Market was valued at USD 4.9 billion in 2025 and is estimated to grow at a CAGR of 7% to reach USD 9.7 billion by 2035.

Market growth is driven by sustainability demands that reshaped protein sourcing strategies across feed supply chains. Environmental pressures related to emissions and land utilization associated with traditional livestock production are acknowledged as major drivers encouraging integrators, manufacturers, and retailers to reassess protein inputs. Alternative feed proteins are positioned as lower-impact solutions because they rely on side-stream resources and deliver higher protein yields per hectare, while supporting long-term supply resilience. The discussion emphasizes that sustainability goals, regulatory momentum, and innovation collectively accelerated diversification away from conventional feed proteins during this timeframe, laying the foundation for broader commercial adoption across multiple animal production systems worldwide.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $4.9 Billion |
| Forecast Value | $9.7 Billion |
| CAGR | 7% |
Market adoption is further explained through the lens of food security and cost volatility. Rising feed expenses between 2021 and 2023, driven by supply disruptions and geopolitical uncertainty, increased pressure on producers to manage risk. Alternative proteins are portrayed as stabilizing inputs that enabled trials across major animal production categories. Performance outcomes from insect-derived meals, fermented plant proteins, and microbial-based ingredients are described as comparable to traditional imported protein meals, while also reducing dependency on external supply chains. Scientific research focused on digestion, gut functionality, and reduced antibiotic reliance strengthened confidence that alternative feed proteins can support animal health, welfare outcomes, and premium product positioning.
The insect protein segment held 35.1% share in 2025 and is projected to grow at a CAGR of 6.8% from 2026 to 2035. The market description highlights a clear transition away from reliance on single protein sources toward diversified ingredient portfolios. Large-scale feed manufacturers are described as blending insect-based inputs with microbial, algal, fungal, yeast-derived, and processed soy proteins. This combined approach is positioned to balance cost management, sustainability messaging, nutritional consistency, amino acid optimization, and additional functional benefits related to gut health and feed efficiency.
The poultry segment held 33.3% share in 2025, with a CAGR of 6.8% through 2035. Strategic investment is described as concentrated in high-margin animal sectors where premium feed formulations can justify higher ingredient costs. Collaborative development between producers and feed formulators is highlighted as a method for creating balanced diets that integrate alternative proteins while supporting claims related to sustainability, reduced reliance on conventional marine proteins, and novel feed inputs within both animal nutrition and companion animal markets.
North America Animal Feed Alternative Protein Market reached USD 1.19 billion in 2024. Growth in the region is attributed to vertically integrated producers seeking supply security and environmental alignment. Strong demand from poultry, specialty feed, and pet nutrition segments continues to support the adoption of fermented, yeast-based, and single-cell proteins. The United States is identified as the dominant national market, supported by advanced fermentation infrastructure, retailer-led sustainability commitments, and consistent demand for antibiotic-free and premium-positioned feed solutions that partially replace conventional soymeal.
The competitive landscape includes ADM, Calysta Inc, Angel Yeast, Innova Feed, CJ Selecta, Hamlet Protein A/S, Titan Biotech Ltd, CHS Inc, E.I. Du Pont De Nemours And Company, Agriprotein GmbH, Deep Branch Biotechnology, AB Mauri, and Crescent Biotech, all of which are actively shaping the development and commercialization of alternative feed protein solutions across global markets. Companies operating in the animal feed alternative protein market are described as strengthening their positions through capacity expansion, technology investment, and strategic partnerships. Many players are focusing on scaling fermentation and insect production systems to improve cost competitiveness and supply reliability. Portfolio diversification is emphasized as firms integrate multiple protein formats to meet varying nutritional and regulatory requirements.